secwatch / observer
8-K filed February 23, 2023, 6:59 PM ET ticker GERN CIK 0000886744
leadership confidence high sentiment neutral materiality 0.50

Director Karin Eastham to retire from Geron board; CEO and COO bonus targets raised

GERON CORP

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Karin Eastham

Director
GERN · GERON CORP
Effective
2023-05-31
Filed
February 23, 2023, 6:59 PM ET
On February 22, 2023, Karin Eastham, a Class III member of the Company’s Board, notified the Board of her retirement from the Company’s Board after 13 years of service on the Company’s Board and imetelstat’s achievement of positive top-line results in the IMerge Phase 3 trial in lower risk myelodysplastic syndromes.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Karin Eastham retired as Director at GERON CORP.

Action
retired
Role
Director
Exact text from the filing
On February 22, 2023, Karin Eastham, a Class III member of the Company’s Board, notified the Board of her retirement from the Company’s Board after 13 years of service on the Company’s Board and imetelstat’s achievement of positive top-line results in the IMerge Phase 3 trial in lower risk myelodysplastic syndromes.
View on SEC.gov

GERON CORP filing history →

Source: SEC EDGAR
accession 0000950170-23-004177
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.